Athersys (NASDAQ:ATHX) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX) in a report published on Saturday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.

Athersys Price Performance

The firm has a market capitalization of $833,000.00, a P/E ratio of -0.01 and a beta of -0.90. Athersys has a 52-week low of $0.01 and a 52-week high of $1.99.

About Athersys

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.